Protagonist Therapeutics (PTGX) Depreciation and Depletion (2020 - 2022)
Protagonist Therapeutics (PTGX) reported Depreciation and Depletion of $254000.0 for Q4 2022, up 8.09% on a YoY basis from $235000.0 in Q4 2021, and down 5.93% sequentially from $270000.0 in Q3 2022.
Protagonist Therapeutics (PTGX) Depreciation and Depletion (2020 - 2022) Analysis & Trends
Protagonist Therapeutics (PTGX) has 3 years of Depreciation and Depletion data on file, last reported at $254000.0 in Q4 2022.
- For the quarter ending Q4 2022, Depreciation and Depletion rose 8.09% year-over-year to $254000.0; the trailing twelve-month figure through Dec 2022 stood at $1.0 million (up 26.94% YoY), and the FY2025 full-year result was $1.2 million, up 37.02% from the prior year.
- Depreciation and Depletion eased to $254000.0 in Q4 2022, from $270000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $270000.0 in Q3 2022 to a low of $180000.0 in Q1 2021.
- A 3-year average of $225888.9 and a median of $235000.0 in 2021 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 40.0% in 2022, while the deepest fall reached 8.09% in 2022.
- Tracing PTGX's Depreciation and Depletion over 3 years: stood at $188000.0 in 2020, then rose by 25.0% to $235000.0 in 2021, then rose by 8.09% to $254000.0 in 2022.
- Business Quant data shows PTGX's Depreciation and Depletion at $254000.0 in Q4 2022, $270000.0 in Q3 2022, and $259000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 39.39 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | Protagonist Therapeutics | 8.88 Bn | 8.88 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 254,000.00 |
| Dec 31, 2022 | 254,000.00 |
| Sep 30, 2022 | 270,000.00 |
| Sep 30, 2022 | 270,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Jun 30, 2022 | 259,000.00 |
| Mar 31, 2022 | 249,000.00 |
| Mar 31, 2022 | 249,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Dec 31, 2021 | 235,000.00 |
| Sep 30, 2021 | 213,000.00 |
| Sep 30, 2021 | 213,000.00 |
| Jun 30, 2021 | 185,000.00 |
| Jun 30, 2021 | 185,000.00 |
| Mar 31, 2021 | 180,000.00 |
| Mar 31, 2021 | 180,000.00 |
| Dec 31, 2020 | 188,000.00 |
| Dec 31, 2020 | 188,000.00 |